What you can learn from one gene: GLI3

Journal of Medical Genetics

Volumn 43, Issue 6, 2006, Pages 465-469

  Biesecker, Leslie ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GLI3; UNCLASSIFIED DRUG;

DIFFERENTIAL DIAGNOSIS; GENE MUTATION; GREIG CEPHALOPOLYSYNDACTYLY; HUMAN; PALLISTER HALL SYNDROME; PATHOPHYSIOLOGY; PHENOTYPE; PLEIOTROPY; POLYDACTYLY; PRIORITY JOURNAL; REVIEW;

ABNORMALITIES, MULTIPLE; ANIMALS; EVOLUTION, MOLECULAR; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MODELS, ANIMAL; MUTATION; NERVE TISSUE PROTEINS; PHENOTYPE; POLYDACTYLY; SYNDROME;

EID: 33745247359     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2004.029181     Document Type: Review

References (29)

1. Vortkamp A, Gessler M, Grzeschik K-H. GLI3 zinc finger gene interrupted by translocations in Greig syndrome families. Nature 1991;352:539-40.
2. Cassidy SB, Allanson JE. Management of genetic syndromes, 2nd edition. Hoboken, NJ: Wiley-Liss, 2005.
3. Baraitser M, Winter RM, Brett EM. Greig cephalopolysyndactyly: report of 13 affected individuals in three families. Clin Genet 1983;24:257-65.
4. Kang S, Allen J, Graham JM, Grebe T, Clericuzio C, Patronas N, Ondrey F, Green E, Schaffer A, Abbott M, Biesecker LG. Linkage mapping and phenotypic analysis of autosomal dominant Pallister-Hall syndrome. J Med Genet 1997;34:441-6.
5. Kang S, Graham JM, Olney AH, Biesecker LG. GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. Nat Genet 1997;15:266-8.
6. Vortkamp A, Gessler M, Grzeschik KH. Identification of optimized target sequences for the GLI3 zinc finger protein. DNA Cell Biol 1995;14:629-34.
7. Villavicencio EH, Walterhouse DO, Iannaccone PM. The sonic hedgehog-patched-Gli pathway in human development and disease. Am J Hum Genet 2000;67:1047-54.
8. Aza-Blanc P, Kornberg T. Ci: a complex transducer of the Hedgehog signal. Trends Genet 1999;15:458-62.
9. Aza-Blanc P, Ramírez-Weber F-A, Laget M-P, Schwartz C, Kornberg TB. Proteolysis that is inhibited by hedgehog targets Cubitus interruptus protein to the nucleus and converts it to a repressor. Cell 1997;89:1043-53.
10. Biesecker LG. Strike three for GLI3. Nat Genet 1997;17:259-60.
11. Wang B, Fallon J, Beachy P. Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb. Cell 2000;100:423-34.
12. Winter RM, Schroer RJ, Meyer LC. Hands and feet. In: Stevenson RE, Hall JG, Goodman RM, editors. Human malformations and related anomalies, vol 2. New York: Oxford University Press, 1993:805-43.
13. Biesecker LG. Polydadyly: how many disorders and how many genes? Am J Med Genet 2002;112:279-83.
14. Hall JG, Pallister PD, Clarren SK, Beckwith JB, Wiglesworth FW, Fraser FC, Cho S, Benke PJ, Reed SD. Congenital hypothalamic hamartoblastoma, hypopituitarism, imperforate anus, and postaxial polydactyly - a new syndrome? Part I. Clinical, causal, and pathogenetic considerations. Am J Med Genet 1980;7:47-74.
15. Duncan PA, Klein RM, Wilmot PL, Shapiro LR. Greig cephalopolysyndadyly syndrome. Am J Dis Child 1979;133:818-21.
16. Radhakrishna U, Bornholdt D, Scott HS, Patel UC, Rossier C, Engel H, Bottani A, Chandal D, Blouin JL, Solanki JV, Grzeschik KH, Antonarakis SE. The phenotypic spectrum of GLI3 morphopathies includes autosomal dominant preaxial polydactyly type-IV and postaxial polydactyly type- A/B; no phenotype prediction from the position of GLI3 mutations. Am J Hum Genet 1999;65:645-55.
17. Johnston JJ, Olivos-Glander I, Killoran C, Elson E, Turner JT, Peters KF, Abbott MH, Aughton DJ, Aylsworth AS, Bamshad MJ, Booth C, Curry CJ, David A, Dinulos MB, Flannery DB, Fox MA, Graham JM, Grange DK, Guttmacher AE, Hannibal MC, Henn W, Hennekam RC, Holmes LB, Hoyme HE, Leppig KA, Lin AE, Macleod P, Manchester DK, Marcelis C, Mazzanti L, McCann E, McDonald MT, Mendelsohn NJ, Moeschler JB, Moghaddam B, Neri G, Newbury-Ecob R, Pagon RA, Phillips JA, Sadler LS, Stoler JM, Tilstra D, Walsh Vockley CM, Zackai EH, Zadeh TM, Brueton L, Black GC, Biesecker LG. Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations. Am J Hum Genet 2005;76:609-22.
18. Shin S, Kogerman P, Lindström E, Toftgard R, Biesecker LG. GLI3 mutations in human disorders mimic Drosophila Cubitus interruptus protein functions and localization. Proc Natl Acad Sci USA 1999;96:2880-4.
19. Gorlin RJ, Cohen MM, Hennekam RCM, editors. Greig cephalopolysyndactyly syndrome. In: Syndromes of the head and neck, 4th edition. New York: Oxford University Press, 2001;995-6).
20. Brueton LA, Chotai KA, van Herwerden L, Schinzel A, Winter RM. The acrocallosal syndrome and Greig syndrome are not allelic disorders. J Med Genet 1992;29:635-7.
21. Legius E, Fryns JP, Casaer P, Boel M, Eggermont E. Schinzel acrocallosal syndrome: a variant example of the Greig syndrome? Ann Genet 1985;28:239-40.
22. Debeer P, Peeters H, Driess S, De Smet L, Freese K, Matthijs G, Bornholdt D, Devriendt K, Grzeschik KH, Fryns JP, Kalff-Suske M. Variable phenotype in Greig cephalopolysyndactyly syndrome: clinical and radiological findings in 4 independent families and 3 sporadic cases with identified GLI3 mutations. Am J Med Genet 2003;120:49-58.
23. Johnston JJ, Olivos-Glander I, Turner J, Aleck K, Bird LM, Mehta L, Schimke RN, Heilstedt H, Spence JE, Blancato J, Biesecker LG. Clinical and molecular delineation of the Greig cephalopolysyndactyly contiguous gene deletion syndrome and its distinction from acrocallosal syndrome. Am J Med Genet 2003;123:236-42.
24. Kroisel PM, Petek E, Wagner K. Phenotype of five patients with Greig syndrome and microdeletion of 7p13. Am J Med Genet 2001;102:243-9.
25. Chu CS, Trapnell BC, Curristin S, Cutting GR, Crystal RG. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet 1993;3:151-6.
26. Biesecker LG. GLI3 and the Pallister-Hall and Greig cephalopolysyndactyly syndromes. In: Epstein O, Erickson RP, Wynshaw-Boris A, editors. Inborn errors of development: the molecular basis of clinical disorders of morphogenesis. Oxford: Oxford University Press, 2004:257-64.
27. Boudreau EA, Liow K, Frattali CM, Wiggs E, Turner JT, Feuillan P, Sato S, Patsalides A, Patronas N, Biesecker LG, Theodore WH. Hypothalamic hamartomas and seizures: distinct natural history of isolated and Pallister-Hall syndrome cases. Epilepsia 2005;46:42-7.
28. Ondrey F, Griffith A, Van Woes C, Rudy S, Peters K, McCullagh L, Biesecker LG. Asymptomatic laryngeal malformations are common in patients with Pallister-Hall syndrome. Am J Med Genet 2000;94:64-7.
29. Fujioka H, Ariga T, Horiuchi K, Otsu M, Igawa H, Kawashima K, Yamamoto Y, Sugihara T, Sakiyama Y. Molecular analysis of non-syndromic preaxial polydactyly: preaxial polydactyly type-IV and preaxial polydactyly type-I. Clin Genet 2005;67:429-33.